Previous chapter:
Chapter 370 Emperor’s Day With a Hiccup
Next chapter:
Chapter 372 Reporting back to Versailles
PREVIEW
... ved choosing adjuvants, substances that enhance the body's immune response to the vaccine, and stabilizers to prolong the vaccine's shelf-life.
Day 11-12: The vaccine prototype was then tested on a small group of healthy adult volunteers from the hospital staff, starting with low doses. These initial human trials were critical to ensure that the vaccine did not cause adverse reactions in humans.
Day 13: With no immediate adverse reactions observed, the dosage was gradually increa ...
YOU MAY ALSO LIKE